On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Yuichiro� Doki

ResearcherPublications, citations & collaboration network

Yuichiro� Doki is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Yuichiro� Doki have?

ScholarIQindexed works

Yuichiro� Doki has 2,275 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Yuichiro� Doki have?

ScholarIQcitation count

Yuichiro� Doki has 52,620 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Yuichiro� Doki?

ScholarIQh-index

Yuichiro� Doki has an h-index of 103 in OpenAlex.

What is the i10-index of Yuichiro� Doki?

ScholarIQi10-index

Yuichiro� Doki has an i10-index of 942 in OpenAlex.

What is the ORCID of Yuichiro� Doki?

ScholarIQorcid

The ORCID for Yuichiro� Doki is on the source record.

What is the OpenAlex record for Yuichiro� Doki?

ScholarIQopenalex

The OpenAlex for Yuichiro� Doki is on the source record.

What are the most-cited papers on Yuichiro� Doki?

ScholarIQmost cited works
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chìn, Shigenori Kadowaki, Myung‐Ju Ahn, Yasuo Hamamoto, Yuichiro� Doki, Chueh‐Chuan Yen, Yutaro Kubota, Sung‐Bae Kim, Chih‐Hung Hsu, Eva Holtved, Ioannis Xynos, Mamoru Kodani, Yuko Kitagawa
The Lancet Oncology. 20191,250 CitationsOPEN ACCESS
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, Yuji Nagano, Daisuke Sugiyama, Koji Atarashi, Yuka Maeda, Masahide Hamaguchi, Naganari Ohkura, Eiichi Sato, Hirotsugu Nagase, Junichi Nishimura, Hirofumi Yamamoto, Shuji Takiguchi, Takeshi Tanoue, Wataru Suda, Hidetoshi Morita, Masahira Hattori, Kenya Honda, Masaki Mori, Yuichiro� Doki, Shimon Sakaguchi
Nature Medicine. 2016897 Citations
Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs
Norikatsu Miyoshi, Hideshi Ishii, Hiroaki Nagano, Naotsugu Haraguchi, Dyah Laksmi Dewi, Yoshihiro Kano, Shinpei Nishikawa, Masahiro Tanemura, Koshi Mimori, Fumiaki Tanaka, Toshiyuki Saito, Junichi Nishimura, Ichiro Takemasa, Tsunekazu Mizushima, Masataka Ikeda, Hirofumi Yamamoto, Mitsugu Sekimoto, Yuichiro� Doki, Masaki Mori
Cell stem cell. 2011755 CitationsOPEN ACCESS
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi, Hideshi Ishii, Koshi Mimori, Fumiaki Tanaka, Masahisa Ohkuma, Ho Min Kim, Hirofumi Akita, Daisuke Takiuchi, Hisanori Hatano, Hiroaki Nagano, Graham F. Barnard, Yuichiro� Doki, Masaki Mori
Journal of Clinical Investigation. 2010606 CitationsOPEN ACCESS
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Yuko Kitagawa, Takashi Uno, Tsuneo Oyama, Ken Kato, Hiroyuki Kato, Hirofumi Kawakubo, Osamu Kawamura, Motoyasu Kusano, Hiroyuki Kuwano, Hiroya Takeuchi, Yasushi Toh, Yuichiro� Doki, Yoshio Naomoto, Kenji Nemoto, Eisuke Booka, Hisahiro Matsubara, Tatsuya Miyazaki, Manabu Muto, Akio Yanagisawa, Masahiro Yoshida
Esophagus. 2018593 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial